This case-based session on glycemic management explores the evolving role of Continuous Glucose Monitoring (CGM) in optimizing diabetes care through real-world clinical scenarios. The discussion begins with key updates in CGM-guided therapy and modern glycemic targets, followed by an expert-led case discussion highlighting practical challenges in treatment individualization, glucose variability, hypoglycemia prevention, and therapy optimization. Through interactive dialogue and clinical insights, the session aims to help clinicians translate CGM data into meaningful therapeutic decisions for improved patient outcomes.

Optimizing Glycemic Control in the CGM Era: A Case-Based Discussion

This session explores the evolving paradigm of cardio-renal-metabolic care, highlighting how SGLT2 inhibitor and DPP-4 inhibitor combinations can improve outcomes in patients with type 2 diabetes and associated co-morbidities. It focuses on mechanisms, patient selection, real-world evidence, and practical strategies to achieve comprehensive heart, kidney, and metabolic protection in routine clinical practice.

Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2i+DPP4i combinations

FICP President, Indian Diabetes, Research Foundation (IDRF), Chairman - Dr A Ramachandran’s Diabetes Hospitals, Chennai

This comprehensive session focuses on simplifying type 2 diabetes management through practical insights on DPP-4 inhibitors, with a special emphasis on linagliptin and its role across the disease trajectory. The discussion covers patient selection, renal considerations, cardiovascular safety, long-term glycemic durability, and real-world positioning in diverse clinical scenarios. A clinically oriented update designed to support confident, individualized diabetes care in everyday practice.

Dr. A Ramachandran

3

1.4k

32.8k

4.8

Upcoming Sessions

Sessions Taken

553

4.9

970

4.7